These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 37161701)
1. Anti-Tumoural [NHC(thiolato)] Gold(I) Complexes Derived from HIF-1α Inhibitor AC1-004 Target the Mitochondrial Redox System and Show Antiangiogenic Effects in vivo. Schleser SW; Köhler LHF; Riethmüller F; Reich S; Fertig R; Schlotte L; Seib J; Goller A; Begemann G; Kempe R; Schobert R Chempluschem; 2023 May; 88(5):e202300167. PubMed ID: 37161701 [TBL] [Abstract][Full Text] [Related]
2. Gold(I) NHC Complexes: Antiproliferative Activity, Cellular Uptake, Inhibition of Mammalian and Bacterial Thioredoxin Reductases, and Gram-Positive Directed Antibacterial Effects. Schmidt C; Karge B; Misgeld R; Prokop A; Franke R; Brönstrup M; Ott I Chemistry; 2017 Feb; 23(8):1869-1880. PubMed ID: 27865002 [TBL] [Abstract][Full Text] [Related]
3. Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl Truong D; Sullivan MP; Tong KKH; Steel TR; Prause A; Lovett JH; Andersen JW; Jamieson SMF; Harris HH; Ott I; Weekley CM; Hummitzsch K; Söhnel T; Hanif M; Metzler-Nolte N; Goldstone DC; Hartinger CG Inorg Chem; 2020 Mar; 59(5):3281-3289. PubMed ID: 32073260 [TBL] [Abstract][Full Text] [Related]
4. A TrxR inhibiting gold(I) NHC complex induces apoptosis through ASK1-p38-MAPK signaling in pancreatic cancer cells. Cheng X; Holenya P; Can S; Alborzinia H; Rubbiani R; Ott I; Wölfl S Mol Cancer; 2014 Sep; 13():221. PubMed ID: 25253202 [TBL] [Abstract][Full Text] [Related]
5. Novel triazolium based 11(th) group NHCs: synthesis, characterization and cellular response mechanisms. Pellei M; Gandin V; Marinelli M; Orsetti A; Del Bello F; Santini C; Marzano C Dalton Trans; 2015 Dec; 44(48):21041-52. PubMed ID: 26587827 [TBL] [Abstract][Full Text] [Related]
6. Characterization of Hydrophilic Gold(I) N-Heterocyclic Carbene (NHC) Complexes as Potent TrxR Inhibitors Using Biochemical and Mass Spectrometric Approaches. Karaca Ö; Scalcon V; Meier-Menches SM; Bonsignore R; Brouwer JMJL; Tonolo F; Folda A; Rigobello MP; Kühn FE; Casini A Inorg Chem; 2017 Nov; 56(22):14237-14250. PubMed ID: 29095609 [TBL] [Abstract][Full Text] [Related]
7. Modulating the Chemical Reactivity of Gold Complexes in Living Systems: From Concept to Biomedical Applications. Jiang J; Xiong X; Zou T Acc Chem Res; 2023 May; 56(9):1043-1056. PubMed ID: 37079555 [TBL] [Abstract][Full Text] [Related]
8. Investigations of the reactivity, stability and biological activity of halido (NHC)gold(I) complexes. Goetzfried SK; Kapitza P; Gallati CM; Nindl A; Cziferszky M; Hermann M; Wurst K; Kircher B; Gust R Dalton Trans; 2022 Jan; 51(4):1395-1406. PubMed ID: 34989741 [TBL] [Abstract][Full Text] [Related]
9. Revisiting the anticancer properties of phosphane(9-ribosylpurine-6-thiolato)gold(I) complexes and their 9H-purine precursors. Kober L; Schleser SW; Bär SI; Schobert R J Biol Inorg Chem; 2022 Dec; 27(8):731-745. PubMed ID: 36244017 [TBL] [Abstract][Full Text] [Related]
10. Cationic and Neutral N-Heterocyclic Carbene Gold(I) Complexes: Cytotoxicity, NCI-60 Screening, Cellular Uptake, Inhibition of Mammalian Thioredoxin Reductase, and Reactive Oxygen Species Formation. Zhang C; Hemmert C; Gornitzka H; Cuvillier O; Zhang M; Sun RW ChemMedChem; 2018 Jun; 13(12):1218-1229. PubMed ID: 29603648 [TBL] [Abstract][Full Text] [Related]
11. Halo and Pseudohalo Gold(I)-NHC Complexes Derived from 4,5-Diarylimidazoles with Excellent Bian M; Fan R; Jiang G; Wang Y; Lu Y; Liu W J Med Chem; 2020 Sep; 63(17):9197-9211. PubMed ID: 32787098 [TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro evaluation of N-heterocyclic carbene gold(I) complexes of the benzimidazolylidene type. Rubbiani R; Can S; Kitanovic I; Alborzinia H; Stefanopoulou M; Kokoschka M; Mönchgesang S; Sheldrick WS; Wölfl S; Ott I J Med Chem; 2011 Dec; 54(24):8646-57. PubMed ID: 22039997 [TBL] [Abstract][Full Text] [Related]
13. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties. Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862 [TBL] [Abstract][Full Text] [Related]
14. Anticancer profile of a series of gold(III) (2-phenyl)pyridine complexes. Rubbiani R; Zehnder TN; Mari C; Blacque O; Venkatesan K; Gasser G ChemMedChem; 2014 Dec; 9(12):2781-90. PubMed ID: 25377650 [TBL] [Abstract][Full Text] [Related]
15. Gold(I) N-heterocyclic carbene complexes with naphthalimide ligands as combined thioredoxin reductase inhibitors and DNA intercalators. Meyer A; Oehninger L; Geldmacher Y; Alborzinia H; Wölfl S; Sheldrick WS; Ott I ChemMedChem; 2014 Aug; 9(8):1794-800. PubMed ID: 24803348 [TBL] [Abstract][Full Text] [Related]